1 ture (n = 18), malignant stricture (n = 12), choledochal cyst (n = 5), choledocholithiasis (n = 3), i

2 from 32 subjects (20 with biliary atresia or choledochal cyst and 12 controls) were tested.

3 9%) an operation to treat biliary atresia or choledochal cyst in the preceding year.

4 alse-positive findings); four demonstrated a choledochal cyst; and two were equivocal.

5                                              Choledochal cysts (CCs) are rare, with risk of infection

6      Extrahepatic biliary atresia (EHBA) and choledochal cysts (CDC) are important causes of obstruct

7             However, most surgical series of choledochal cysts have reported few choledochoceles beca

8 r suppressor gene nf2, develops extrahepatic choledochal cysts in the common bile duct, suggesting th

9 erefore, we conclude that classifications of choledochal cysts should not include choledochoceles.

10 th choledochoceles differ from patients with choledochal cysts with respect to age, gender, presentat

11                A total of 146 patients with "choledochal cysts" including 45 children (31%) and 28 wi

12 iary cirrhosis, cholangitis, cholelithiasis, choledochal cysts, hepatitis B virus, hepatitis C virus,

13 11 for bile duct injury, cholangiocarcinoma, choledochal cysts, or benign strictures; the procedures

14 edochoceles to Todani Types I, II, IV, and V choledochal cysts.

15 bserved in biliary cells in individuals with choledochal cysts.

16 eles have been classified as Todani Type III choledochal cysts.

17 iversity Hospitals to identify patients with choledochal cysts.